Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Overview: an iPS cell stock at CiRA

1 Sept 2019

Abstract excerpt

Induced pluripotent stem cells (iPSCs) can be produced from various somatic cells and have the ability to differentiate into various cells and tissues of the body. Regenerative medicine using iPSCs is expected to manage diseases lacking effective treatments at present. We are establishing a safe and effective iPSC stock that can be used for regenerative medicine. Our iPSC stock is recruited from healthy,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomedical Ethics and Regulation
Share to CRISPR and Genetic Engineering
Share to Pluripotent Stem Cells Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31497180
DOI: 10.1186/s41232-019-0106-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Overview: an iPS cell stock at CiRAPMID 31497180Read ↗

CiRA iPSC seed stocks (CiRA's iPSC Stock Project)Semantic proximity Read ↗

A clinical-grade HLA haplobank of human induced pluripotent stem cells matching approximately 40% of the Japanese populationSemantic proximity Read ↗

Recent progress of national banking project on homozygous HLA ‐typed induced pluripotent stem cells in S outh K oreaSemantic proximity Read ↗

Prospects of Induced Pluripotent Stem Cell Technology in Regenerative MedicineSemantic proximity Read ↗

Current advances in the generation of human iPS cells: implications in cell-based regenerative medicineSemantic proximity Read ↗

iPS Cells—The Triumphs and TribulationsSemantic proximity Read ↗

Haplobanking induced pluripotent stem cells for clinical useSemantic proximity Read ↗

Current Landscape of iPSC HaplobanksSemantic proximity Read ↗

Establishment of the Saudi Bank of Induced Pluripotent Stem Cells (SBiPSCs): A National Platform for iPSC-Based Research and TherapySemantic proximity Read ↗

Establishment of the Saudi Bank of Induced Pluripotent Stem Cells (SBiPSCs): A National Platform for iPSC-Based Research and TherapySemantic proximity Read ↗

Current status and future perspectives of HLA-edited induced pluripotent stem cellsSemantic proximity Read ↗

Potential and Limitation of HLA-Based Banking of Human Pluripotent Stem Cells for Cell TherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.